Global Human Erythropoietin Market Research Report 2022
SKU ID :QYR-21606626 | Published Date: 05-Sep-2022 | No. of pages: 81Description
TOC
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Erythropoietin Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Epoetin-alfa
1.2.3 Epoetin-beta
1.2.4 Darbepoetin-alfa
1.2.5 Others
1.3 Market by Application
1.3.1 Global Human Erythropoietin Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Anemia
1.3.3 Kidney Disorders
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Human Erythropoietin Market Perspective (2017-2028)
2.2 Human Erythropoietin Growth Trends by Region
2.2.1 Human Erythropoietin Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Human Erythropoietin Historic Market Size by Region (2017-2022)
2.2.3 Human Erythropoietin Forecasted Market Size by Region (2023-2028)
2.3 Human Erythropoietin Market Dynamics
2.3.1 Human Erythropoietin Industry Trends
2.3.2 Human Erythropoietin Market Drivers
2.3.3 Human Erythropoietin Market Challenges
2.3.4 Human Erythropoietin Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Erythropoietin Players by Revenue
3.1.1 Global Top Human Erythropoietin Players by Revenue (2017-2022)
3.1.2 Global Human Erythropoietin Revenue Market Share by Players (2017-2022)
3.2 Global Human Erythropoietin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human Erythropoietin Revenue
3.4 Global Human Erythropoietin Market Concentration Ratio
3.4.1 Global Human Erythropoietin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Erythropoietin Revenue in 2021
3.5 Human Erythropoietin Key Players Head office and Area Served
3.6 Key Players Human Erythropoietin Product Solution and Service
3.7 Date of Enter into Human Erythropoietin Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Erythropoietin Breakdown Data by Type
4.1 Global Human Erythropoietin Historic Market Size by Type (2017-2022)
4.2 Global Human Erythropoietin Forecasted Market Size by Type (2023-2028)
5 Human Erythropoietin Breakdown Data by Application
5.1 Global Human Erythropoietin Historic Market Size by Application (2017-2022)
5.2 Global Human Erythropoietin Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Human Erythropoietin Market Size (2017-2028)
6.2 North America Human Erythropoietin Market Size by Country (2017-2022)
6.3 North America Human Erythropoietin Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Human Erythropoietin Market Size (2017-2028)
7.2 Europe Human Erythropoietin Market Size by Country (2017-2022)
7.3 Europe Human Erythropoietin Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Erythropoietin Market Size (2017-2028)
8.2 Asia-Pacific Human Erythropoietin Market Size by Country (2017-2022)
8.3 Asia-Pacific Human Erythropoietin Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Human Erythropoietin Market Size (2017-2028)
9.2 Latin America Human Erythropoietin Market Size by Country (2017-2022)
9.3 Latin America Human Erythropoietin Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Erythropoietin Market Size (2017-2028)
10.2 Middle East & Africa Human Erythropoietin Market Size by Country (2017-2022)
10.3 Middle East & Africa Human Erythropoietin Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Human Erythropoietin Introduction
11.1.4 Amgen Revenue in Human Erythropoietin Business (2017-2022)
11.1.5 Amgen Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Human Erythropoietin Introduction
11.2.4 Johnson & Johnson Revenue in Human Erythropoietin Business (2017-2022)
11.2.5 Johnson & Johnson Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Human Erythropoietin Introduction
11.3.4 Roche Revenue in Human Erythropoietin Business (2017-2022)
11.3.5 Roche Recent Development
11.4 Galenica
11.4.1 Galenica Company Detail
11.4.2 Galenica Business Overview
11.4.3 Galenica Human Erythropoietin Introduction
11.4.4 Galenica Revenue in Human Erythropoietin Business (2017-2022)
11.4.5 Galenica Recent Development
11.5 Emcure
11.5.1 Emcure Company Detail
11.5.2 Emcure Business Overview
11.5.3 Emcure Human Erythropoietin Introduction
11.5.4 Emcure Revenue in Human Erythropoietin Business (2017-2022)
11.5.5 Emcure Recent Development
11.6 Kyowa Hakko Kirin
11.6.1 Kyowa Hakko Kirin Company Detail
11.6.2 Kyowa Hakko Kirin Business Overview
11.6.3 Kyowa Hakko Kirin Human Erythropoietin Introduction
11.6.4 Kyowa Hakko Kirin Revenue in Human Erythropoietin Business (2017-2022)
11.6.5 Kyowa Hakko Kirin Recent Development
11.7 3SBio
11.7.1 3SBio Company Detail
11.7.2 3SBio Business Overview
11.7.3 3SBio Human Erythropoietin Introduction
11.7.4 3SBio Revenue in Human Erythropoietin Business (2017-2022)
11.7.5 3SBio Recent Development
11.8 Biocon
11.8.1 Biocon Company Detail
11.8.2 Biocon Business Overview
11.8.3 Biocon Human Erythropoietin Introduction
11.8.4 Biocon Revenue in Human Erythropoietin Business (2017-2022)
11.8.5 Biocon Recent Development
11.9 LG Life Sciences
11.9.1 LG Life Sciences Company Detail
11.9.2 LG Life Sciences Business Overview
11.9.3 LG Life Sciences Human Erythropoietin Introduction
11.9.4 LG Life Sciences Revenue in Human Erythropoietin Business (2017-2022)
11.9.5 LG Life Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Tables & Figures
List of Tables
Table 1. Global Human Erythropoietin Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Epoetin-alfa
Table 3. Key Players of Epoetin-beta
Table 4. Key Players of Darbepoetin-alfa
Table 5. Key Players of Others
Table 6. Global Human Erythropoietin Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Human Erythropoietin Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Human Erythropoietin Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Human Erythropoietin Market Share by Region (2017-2022)
Table 10. Global Human Erythropoietin Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Human Erythropoietin Market Share by Region (2023-2028)
Table 12. Human Erythropoietin Market Trends
Table 13. Human Erythropoietin Market Drivers
Table 14. Human Erythropoietin Market Challenges
Table 15. Human Erythropoietin Market Restraints
Table 16. Global Human Erythropoietin Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Human Erythropoietin Market Share by Players (2017-2022)
Table 18. Global Top Human Erythropoietin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Erythropoietin as of 2021)
Table 19. Ranking of Global Top Human Erythropoietin Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Human Erythropoietin Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Human Erythropoietin Product Solution and Service
Table 23. Date of Enter into Human Erythropoietin Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Human Erythropoietin Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Human Erythropoietin Revenue Market Share by Type (2017-2022)
Table 27. Global Human Erythropoietin Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Human Erythropoietin Revenue Market Share by Type (2023-2028)
Table 29. Global Human Erythropoietin Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Human Erythropoietin Revenue Market Share by Application (2017-2022)
Table 31. Global Human Erythropoietin Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Human Erythropoietin Revenue Market Share by Application (2023-2028)
Table 33. North America Human Erythropoietin Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Human Erythropoietin Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Human Erythropoietin Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Human Erythropoietin Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Human Erythropoietin Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Human Erythropoietin Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Human Erythropoietin Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Human Erythropoietin Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Human Erythropoietin Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Human Erythropoietin Market Size by Country (2023-2028) & (US$ Million)
Table 43. Amgen Company Detail
Table 44. Amgen Business Overview
Table 45. Amgen Human Erythropoietin Product
Table 46. Amgen Revenue in Human Erythropoietin Business (2017-2022) & (US$ Million)
Table 47. Amgen Recent Development
Table 48. Johnson & Johnson Company Detail
Table 49. Johnson & Johnson Business Overview
Table 50. Johnson & Johnson Human Erythropoietin Product
Table 51. Johnson & Johnson Revenue in Human Erythropoietin Business (2017-2022) & (US$ Million)
Table 52. Johnson & Johnson Recent Development
Table 53. Roche Company Detail
Table 54. Roche Business Overview
Table 55. Roche Human Erythropoietin Product
Table 56. Roche Revenue in Human Erythropoietin Business (2017-2022) & (US$ Million)
Table 57. Roche Recent Development
Table 58. Galenica Company Detail
Table 59. Galenica Business Overview
Table 60. Galenica Human Erythropoietin Product
Table 61. Galenica Revenue in Human Erythropoietin Business (2017-2022) & (US$ Million)
Table 62. Galenica Recent Development
Table 63. Emcure Company Detail
Table 64. Emcure Business Overview
Table 65. Emcure Human Erythropoietin Product
Table 66. Emcure Revenue in Human Erythropoietin Business (2017-2022) & (US$ Million)
Table 67. Emcure Recent Development
Table 68. Kyowa Hakko Kirin Company Detail
Table 69. Kyowa Hakko Kirin Business Overview
Table 70. Kyowa Hakko Kirin Human Erythropoietin Product
Table 71. Kyowa Hakko Kirin Revenue in Human Erythropoietin Business (2017-2022) & (US$ Million)
Table 72. Kyowa Hakko Kirin Recent Development
Table 73. 3SBio Company Detail
Table 74. 3SBio Business Overview
Table 75. 3SBio Human Erythropoietin Product
Table 76. 3SBio Revenue in Human Erythropoietin Business (2017-2022) & (US$ Million)
Table 77. 3SBio Recent Development
Table 78. Biocon Company Detail
Table 79. Biocon Business Overview
Table 80. Biocon Human Erythropoietin Product
Table 81. Biocon Revenue in Human Erythropoietin Business (2017-2022) & (US$ Million)
Table 82. Biocon Recent Development
Table 83. LG Life Sciences Company Detail
Table 84. LG Life Sciences Business Overview
Table 85. LG Life Sciences Human Erythropoietin Product
Table 86. LG Life Sciences Revenue in Human Erythropoietin Business (2017-2022) & (US$ Million)
Table 87. LG Life Sciences Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Erythropoietin Market Share by Type: 2021 VS 2028
Figure 2. Epoetin-alfa Features
Figure 3. Epoetin-beta Features
Figure 4. Darbepoetin-alfa Features
Figure 5. Others Features
Figure 6. Global Human Erythropoietin Market Share by Application in 2021 & 2028
Figure 7. Anemia Case Studies
Figure 8. Kidney Disorders Case Studies
Figure 9. Others Case Studies
Figure 10. Human Erythropoietin Report Years Considered
Figure 11. Global Human Erythropoietin Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Human Erythropoietin Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Human Erythropoietin Market Share by Region: 2021 VS 2028
Figure 14. Global Human Erythropoietin Market Share by Players in 2021
Figure 15. Global Top Human Erythropoietin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Erythropoietin as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Human Erythropoietin Revenue in 2021
Figure 17. North America Human Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Human Erythropoietin Market Share by Country (2017-2028)
Figure 19. United States Human Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Human Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Human Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Human Erythropoietin Market Share by Country (2017-2028)
Figure 23. Germany Human Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Human Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Human Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Human Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Human Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Human Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Human Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Human Erythropoietin Market Share by Region (2017-2028)
Figure 31. China Human Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Human Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Human Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Human Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Human Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Human Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Human Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Human Erythropoietin Market Share by Country (2017-2028)
Figure 39. Mexico Human Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Human Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Human Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Human Erythropoietin Market Share by Country (2017-2028)
Figure 43. Turkey Human Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Human Erythropoietin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Amgen Revenue Growth Rate in Human Erythropoietin Business (2017-2022)
Figure 46. Johnson & Johnson Revenue Growth Rate in Human Erythropoietin Business (2017-2022)
Figure 47. Roche Revenue Growth Rate in Human Erythropoietin Business (2017-2022)
Figure 48. Galenica Revenue Growth Rate in Human Erythropoietin Business (2017-2022)
Figure 49. Emcure Revenue Growth Rate in Human Erythropoietin Business (2017-2022)
Figure 50. Kyowa Hakko Kirin Revenue Growth Rate in Human Erythropoietin Business (2017-2022)
Figure 51. 3SBio Revenue Growth Rate in Human Erythropoietin Business (2017-2022)
Figure 52. Biocon Revenue Growth Rate in Human Erythropoietin Business (2017-2022)
Figure 53. LG Life Sciences Revenue Growth Rate in Human Erythropoietin Business (2017-2022)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Companies
Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences
- PRICE
-
$2900$5800$4350Buy Now